Q2 EPS Estimates for TScan Therapeutics Cut by HC Wainwright
TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) – Equities research analysts at HC Wainwright dropped their Q2 2025 earnings estimates for TScan Therapeutics in a research report issued on Thursday, March 6th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings per share of ($0.32) for the quarter, down from their […]
TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) – Equities research analysts at HC Wainwright dropped their Q2 2025 earnings estimates for TScan Therapeutics in a research report issued on Thursday, March 6th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings per share of ($0.32) for the quarter, down from their […]
